Results 331 to 340 of about 466,412 (376)
Some of the next articles are maybe not open access.
A CASE STUDY OF MULTIPLE SCLEROSIS (MS)
2022This is a CASE STUDY OF MULTIPLE SCLEROSIS (MS) is designed to be a PBL for teaching for Medical students.
openaire +2 more sources
LSN MS guidelines for the management of multiple sclerosis
Revue Neurologique, 2013The prevalence of multiple sclerosis (MS) in Lebanon is unknown, as there are no available or reliable epidemiological studies to date. The circumstances of Middle East countries are different from those of Europe and North America in terms of differential diagnoses and disease management.
K. Kallab +10 more
openaire +3 more sources
Multiple sclerosis specific antigens in MS brains
Acta Neurologica Scandinavica, 2009Antigens in MS and non-MS brains were investigated by means of crossed immunoelectrophoresis. Two MS specific antigens were found: a measles antigen which was present in microsomes and cytosole, and an unidentified antigen present only in cytosole.
J. Clausen, S. C. Rastogi, Torben Fog
openaire +3 more sources
Coffee and multiple sclerosis (MS)
Multiple Sclerosis (MS) is a long-term autoimmune disorder affecting the central nervous system, marked by inflammation, demyelination, and neurodegeneration. While the exact cause of MS remains unknown, recent research indicates that environmental factors, particularly diet, may influence the disease's risk and progression.Youssef K. Ghallab +2 more
openaire +2 more sources
Animal Models of Multiple Sclerosis (MS)
2017Multiple sclerosis is the chronic autoimmune disorder of the sensory system coordinated against its own particular myelin antigens. It is the basic incapacitating neurological illness influencing generally youth and grown-ups between the age of 20 and 40 years. Myelin is a protein that makes up the myelin sheath around the nerve fibers (axons).
Sanpreet Kour +2 more
openaire +2 more sources
Multiple sclerosis–associated retrovirus and MS prognosis
Neurology, 2002MS-associated retrovirus (MSRV) in the CSF may have gliotoxic properties and could be associated with a more disabling MS. The authors tested this hypothesis in 15 untreated patients with MS: 6 MSRV- and 9 MSRV+ at the time of CSF withdrawal. After a 3-year mean follow-up, MSRV- patients showed a stable MS course, whereas MSRV+ patients had a ...
Sotgiu S +6 more
openaire +4 more sources
The nature of benefit finding in multiple sclerosis (MS)
Psychology, Health & Medicine, 2007This study examined the nature of benefit finding in MS and the adequacy of the Benefit Finding Scale (BFS; Mohr et al., 1999) as a comprehensive measure of perceived benefits in MS. A total of 502 people with MS completed questionnaires at Time 1 and 3 months later, Time 2 (n=404).
openaire +4 more sources
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
Neurourology and Urodynamics, 2015Multiple sclerosis (MS) is a unique central nervous system (CNS) inflammatory disease with a broad spectrum of clinical presentations, which are time- and disease progression-related. It usually affects young adults, with a female predominance of 3:1. Men are more likely to develop symptoms at a slightly older age with a more progressive disease course.
Ornella Lam +3 more
openaire +4 more sources
MS Trust critical of guidance on multiple sclerosis
Nursing Standard, 2016The MS Trust is refusing to endorse guidance from the National Institute for Health and Care Excellence because the advice fails to mention nurse specialists.
openaire +2 more sources
Emotional stress and coping in multiple sclerosis (MS) exacerbations
Journal of Psychosomatic Research, 1991Ninety-five pairs of MS patients in exacerbation and remission were compared on emotional stress in the previous three months. Patients in exacerbation scored higher on emotional disturbance and intensity of stressful events than patients in remission, but lower on frequency of compensating uplifts.
K.G. Warren +2 more
openaire +3 more sources